Navigation Links
Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease
Date:1/15/2014

THOUSAND OAKS, Calif., Jan. 15, 2014 /PRNewswire/ -- Massachusetts General Hospital (MGH), the Broad Institute, and Amgen (NASDAQ: AMGN) announced today that they have launched a strategic collaboration to jointly discover and validate new therapeutic targets and develop novel therapies for inflammatory bowel disease (IBD), a chronic disorder that affects millions worldwide. The MGH-Broad-Amgen collaboration brings together scientists with expertise in clinical medicine, IBD biology, human genetics, genomic technology, and drug discovery to work together to help create a new world of therapeutic options for IBD patients.

"We are thrilled to be working together with our Amgen colleagues in this visionary collaboration," said Ramnik Xavier, chief of gastroenterology and director of the Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital and a senior associate member of the Broad Institute. "I look forward to a fruitful collaboration, translating discoveries of IBD genes and biology into novel drugs for IBD patients." 

IBD is well known to run in families, suggesting that genes play a significant role in the development and progression of disease. However, until recently, almost nothing was known about the specific genes and mechanisms that predispose — or protect — someone from developing the disorder. Scientists have now pinpointed more than 150 regions of the genome — up from two just a decade ago — that place a person at risk for developing IBD. Despite the recent progress in understanding the biology of IBD, there remains a critical need:  treatments that make use of scientists' new knowledge are urgently needed. While drugs developed over the last decade have led to some marked improvements in IBD treatment, the drugs are not always effective a
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AMRI Announces Lifting of FDA Warning Letter Related to Burlington, Mass. Facility
2. Leading Pension Annuity Provider Legal & General, Celebrates 175 Years
3. ResearchMoz: The World Anesthesia Drug Market (General, Local, Adjunctive) - Market Research Report
4. Sangamo BioSciences Presents Data From Non-Human Primates Providing Proof Of Concept For Disruptive And Broadly Leverageable Platform For Protein Replacement Therapies
5. Stocks Outperformed the Broader Markets: Facebook Inc, Twitter Inc, CF Industries Holdings, Green Mountain Coffee Roasters, Arca Biopharma
6. B. Braun to Showcase its Broad Pharmacy Portfolio at ASHP
7. Phase 3 data show viral cure rates achieved in a broad range of patients with genotype-1 hepatitis C taking investigational compound faldaprevir plus PegIFN/RBV
8. Bayer and the Broad Institute Join Forces to Develop Novel Treatment Options in Cancer Therapy
9. Trovagene Announces Issuance of Broad MicroRNA Patent
10. Huahai and Oncobiologics Create Broad Biosimilars Partnership
11. Z-Medica Announces Expanded CE Indications for QuikClot Hemostatic Dressings Supporting Broader Use in Surgical Wound Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Mich. , Oct. 31, 2014  Lycera ... modulators to treat autoimmune disease and cancer, today ... novel synthetic RORgamma agonist product candidates will be ... for Immunotherapy of Cancer (SITC) being held November ... Convention Center, National Harbor, MD.  The poster, entitled ...
(Date:10/31/2014)... -- British Journal of Urology International ... "male orgasmic dysfunction" with their doctor prior to any ... while preserving sexual function     ... paper in the British Journal of Urology International which ... with their doctors the likely impact of treatment options ...
(Date:10/31/2014)... DUBLIN , October 30, 2014 ... ) has announced the addition of the  "Process ...  conference to their offering.      (Logo: ... , Science and Risk Based Approach to Process ... Quality Risk Management FDA Process Validation ...
Breaking Medicine Technology:Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2Sexual Dysfunction No Longer Inevitable When Treating Enlarged Prostate 2Process Validation in the US and EU (Workshop, London) 2Process Validation in the US and EU (Workshop, London) 3Process Validation in the US and EU (Workshop, London) 4
... 29, 2010 Reportlinker.com announces that a new ... 2010-2015 In-depth Research Report on ... http://www.reportlinker.com/p0356862/2010-2015-In-depth-Research-Report-on-China-Sodium-Fluoride-Industry.html Report SummaryBased on ... Bureau, General Administration of Custom, Ministry of Commerce ...
... Reportlinker.com announces that a new market research report ... The Outlook for Pharmaceuticals to 2012 ... Pharmaceuticals to 2012 is a new collection of management ... individual and highly-detailed analysis of each market, looking at ...
Cached Medicine Technology:Reportlinker Adds 2010-2015 In-depth Research Report on China Sodium Fluoride Industry 2Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 2Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 3Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 4Reportlinker Adds E7: The Outlook for Pharmaceuticals to 2012 5
(Date:10/31/2014)... (PRWEB) October 31, 2014 Fundraising support for ... greater gains than losses. At noon on Monday, November 10 ... Hospital (SSMH), greater than 20 Susquehanna Health (SH) employees ... to raise awareness and funds for the new Cancer Center ... participants’ heads for this act of love and support to ...
(Date:10/31/2014)... for Healthy Neighborhoods (PRCHN) at Case Western Reserve ... in nearly $13.32 million in federal grants awarded ... The Centers for Disease Control and Prevention (CDC) ... five years. The funds will support the center,s ... environmental, and policy interventions that prevent and reduce ...
(Date:10/31/2014)... Monica Williams-Murphy MD , advanced care planning ... chaos that can occur for people who have not ... Americans who come into the emergency department facing the ... the moment and so are their families." She adds, ... catalyst for a family to get the critical conversations ...
(Date:10/31/2014)... 31, 2014 Activz Whole-Food Nutrition ... Silver line offering natural silver healing support† in ... a century, silver has been used to support natural ... products is the most advanced version available. This latest ... chemical structure that supports the existing healing mechanisms in ...
(Date:10/31/2014)... increases the risk of certain types of breast cancer ... studies show. One study of more than 3,200 ... risk for estrogen receptor-negative and progesterone receptor-positive breast tumors ... long time for white women, but now we are ... John, a senior research scientist at the Cancer Prevention ...
Breaking Medicine News(10 mins):Health News:Susquehanna Health Soldiers + Sailors Memorial Hospital Razing Heads to Fight Cancer 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 2Health News:Case Western Reserve, Cuyahoga County, YMCA of greater Cleveland: Public health grants 3Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 2Health News:This Thanksgiving or Christmas Family Gathering, Use The New App ListStuffFast to Start "The Conversation" With a Parent That Has No Plan For End-of-Life 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Study Confirms Obesity-Breast Cancer Link for Blacks, Hispanics 2
... exercised during pregnancy needed less pain meds, study found ... during pregnancy reduces the amount of pain-killing medication requested ... that included 71 expectant mothers. , Half the ... week of aquarobics during their pregnancy, while the other ...
... the Dallas office of WHR Architects. Ms. Moran, nationally recognized ... Education, Science and Technology practice and broaden the talent base ... , "Anita,s experience and skills complement ... college and university clients," said Mark W. Vaughan AIA, ACHA, ...
... SPRINGFIELD, Mass., Nov. 21 Massachusetts Mutual Life,Insurance ... two,Co-Chief Operating Officers. , ... Officer, Executive Vice President,and Chief Investment Officer, will ... H. Reese, who remains Chairman and Chief Executive,Officer. ...
... NXTM ), a leading manufacturer of innovative ... 2008 Technology Fast 500, a,ranking of the 500 fastest ... America. Rankings are based on percentage of,fiscal year revenue ... more than 20,000 percent during this period. , ...
... by HIV/AIDS in New Jersey and Africa - , ... than 800 local Roche employees are participating in the ... support children infected and affected by HIV/AIDS in New Jersey and ... through the township of Nutley, collect donations for their efforts, and ...
... to take, has fewer side effects than chemotherapy, ... The cancer-fighting pill Iressa works as well as chemotherapy ... , Although neither therapy prolongs survival beyond eight months, ... be a better choice for patients who did not ...
Cached Medicine News:Health News:Aquarobics May Help Ease Labor 2Health News:Anita Moran AIA Joins WHR Dallas 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 2Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 3Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 4Health News:MassMutual Announces Promotions for Two Co-Chief Operating Officers 5Health News:NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500 2Health News:NxStage(R) Ranked 14th Fastest Growing Company in North America on Deloitte's 2008 Technology Fast 500 3Health News:Roche Holds Sixth Annual Children's Walk in Nutley 2Health News:Roche Holds Sixth Annual Children's Walk in Nutley 3Health News:Roche Holds Sixth Annual Children's Walk in Nutley 4Health News:Iressa as Good as Chemotherapy for Lung Cancer 2Health News:Iressa as Good as Chemotherapy for Lung Cancer 3
Toxoplasma IgM II ELISA....
HSV 1 & HSV 2 DFA Test....
Herpes Simplex Virus 2 IgG ELISA....
Herpes Simplex Virus 1 IgG ELISA....
Medicine Products: